Summit Global Investments Fulgent Genetics, Inc. Transaction History

Summit Global Investments

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$47.98 - $62.75 $283,082 - $370,225	-5,900 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$49.85 - $96.11 $294,115 - $567,049	5,900 New	5,900 $368,000
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $231,900 - $315,000	-3,000 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$74.87 - $110.87 $321,941 - $476,741	-4,300 Reduced 58.9%	3,000 $270,000
Q2 2021 Jan 28, 2022	BUY	$66.8 - $100.45 $487,640 - $733,285	7,300 New	7,300 $673,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.